On Saturday, NuCana plc ( NCNA )  presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with Merck & Co Inc's ( MRK ) Keytruda (pembrolizumab) for metastatic melanoma who were refractory to or had relapsed on prior PD-1 inhibitor therapy. In this 12-patient cohort, most patients had received at least two...

09:29 AM EDT, 09/16/2024 (MT Newswires) -- Exact Sciences ( EXAS ) was advancing in Monday's premarket activity, with shares rising over 4%, after the company presented performance data it said showed its blood-based screening test for colorectal cancer had an 88.3% sensitivity for the disease and 31.2% for advanced precancerous lesions. Both tests had a specificity of 90.1% for...

Although U.S. stocks closed higher on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an...

((This Sept. 13 has been corrected to fix the minister's surname throughout, to Sharlapaev from Sharlapayev)) By Olzhas Auyezov and Eric Onstad ALMATY (Reuters) - Kazakhstan aims to boost output of metals needed for electric vehicle (EV) batteries and is issuing hundreds of new exploration licences to attract fresh investment in the sector, the country's industry minister told Reuters. The...